Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
or compare any two companies
Highlights mark the larger figure · financials source-verified · estimates clearly labelled
Abbott India Limited
Pharmaceuticals · India
Abbott India Limited is an Indian pharmaceutical company and a listed subsidiary of Abbott Laboratories. It markets branded prescription and over-the-counter healthcare products across therapeutic areas such as gastroenterology, women's health, metabolic disorders, central nervous system, pain management, and vaccines.
Verified financials
No source-verified financials available.
Strengths
Strong parentage from Abbott Laboratories
Recognized brands in chronic and specialty therapeutic areas
Established doctor and pharmacy distribution network
Focus on higher-margin branded formulations
Weaknesses
High dependence on the Indian domestic pharmaceutical market
Limited scale compared with India's largest pharma companies
Exposure to price controls on essential medicines
Relatively concentrated portfolio in select therapies
Opportunities
Growth in chronic disease treatment demand in India
Expansion in women's health, gastroenterology, and metabolic care
Digital engagement with physicians and patients
Leveraging Abbott's global portfolio for India-specific launches
Threats
Intense competition from Indian generic and branded-generic companies
Regulatory pricing pressure from India's drug price control regime
